Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II crossover study of CHF 1535 NEXT DPI versus pMDI in partly controlled adult asthma
2008-004842-10Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of beclomethasone dipropionate and formoterol in asthma (5 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: FEV1 AUC0-12h standardized by time. Started Nov 2008; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2008-004842-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004842-10.